← Back to Search

Helmet oxygenation group for Hypoxemic Respiratory Failure (NOVA-pilot Trial)

N/A
Waitlist Available
Led By Mark A Tidswell, MD
Research Sponsored by Baystate Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

NOVA-pilot Trial Summary

This trial is testing if a new type of breathing assistance called "helmet NIPPV" is feasible and if it shows promise, a larger trial will be conducted.

Eligible Conditions
  • Hypoxemic Respiratory Failure

NOVA-pilot Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of intubation
Secondary outcome measures
Complications
Confusion Assessment Method for the ICU (CAM-ICU)
Highest level of daily mobility through day 7
+14 more

NOVA-pilot Trial Design

2Treatment groups
Active Control
Group I: Helmet oxygenation groupActive Control1 Intervention
Patients randomized to helmet NIPPV will receive noninvasive oxygenation and ventilation via a latex free helmet
Group II: High Flow Nasal OxygenActive Control1 Intervention
Oxygen will be passed through a heated humidifier and applied continuously through large-bore nasal prongs

Find a Location

Who is running the clinical trial?

Baystate Medical CenterLead Sponsor
63 Previous Clinical Trials
44,272 Total Patients Enrolled
Mark A Tidswell, MDPrincipal InvestigatorBaystate Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Apr 2025